CEACAM7 Antibody [Janelia Fluor® 669]
Novus Biologicals, part of Bio-Techne | Catalog # AF4478JF669

Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Concentration
Product Specifications
Immunogen
Asn37-Phe142
Accession # Q14002
Specificity
Clonality
Host
Isotype
Applications for CEACAM7 Antibody [Janelia Fluor® 669]
Immunohistochemistry
Western Blot
Formulation, Preparation, and Storage
Purification
Formulation
Preservative
Concentration
Shipping
Stability & Storage
Background: CEACAM-7
CEACAM-7 (Carcinoembryonic antigen-related cell adhesion molecule 7; CGM2) is a GPI-anchored glycoprotein that is preferentially expressed on the luminal surface of epithelial cells near the mouth of colonic crypts and on pancreatic ductal epithelial cells. It is downregulated during colorectal adenoma progression but can be upregulated during the development of gastric carcinoma. CEACAM-7 binds to CEACAM-1, consistent with the heterophilic interaction of CEACAM-1 with other CEACAM family members.
Long Name
Alternate Names
Gene Symbol
Additional CEACAM-7 Products
Product Documents for CEACAM7 Antibody [Janelia Fluor® 669]
Product Specific Notices for CEACAM7 Antibody [Janelia Fluor® 669]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.